Skip to main content

Published locations for EMA’s JAK Inhibitor Warning Criteria May Affect Up to 80% of Patients With Rheumatoid Arthritis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EMA’s JAK Inhibitor Warning Criteria May Affect Up to 80% of Patients With Rheumatoid Arthritis

User login

  • Reset your password
  • /content/emas-jak-inhibitor-warning-criteria-may-affect-80-patients-rheumatoid-arthritis
  • /internalmedicinenews/article/269076/rheumatoid-arthritis/emas-jak-inhibitor-warning-criteria-may
  • /rheumatologynews/article/269076/rheumatoid-arthritis/emas-jak-inhibitor-warning-criteria-may-affect
  • /rheumatology/article/269076/rheumatoid-arthritis/emas-jak-inhibitor-warning-criteria-may-affect-80
  • /internalmedicine/article/269076/rheumatoid-arthritis/emas-jak-inhibitor-warning-criteria-may-affect